For instance, despite growing evidence of the protective effects of natural products on ECs through Nrf2/HO‐1 activation, more comprehensive preclinical studies are necessary to further develop new drugs for atherosclerosis and other cardiovascular diseases. The gene discussed is HMOX1; the disease is atherosclerosis.